Mount Rainier Acquisition Corp. - Common Stock (NQ:RNER)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Mount Rainier Acquisition Corp. - Common Stock

3 Hidden Gems in the Penny Stock Market That You Need to Know About ↗

May 11, 2023

Penny stocks can certainly be risky, but these three hidden gems could potentially produce high returns for investors.

Via InvestorPlace

HUBC Stock Alert: What to Know as HUB Cyber Security Starts Trading ↗

March 01, 2023

Investors in de-SPAC company HUB Cyber Security are in selling mode today on the stock's first day of trading, with HUBC stock down big.

Via InvestorPlace

HUB Cyber Security Ltd, a Developer of Confidential Computing Cybersecurity Solutions and Services, Successfully Closes Its Business Combination with Mount Rainier Acquisition Corp.

February 28, 2023

HUB shares to commence trading on the Nasdaq Global Market under the ticker “HUBC” on\n\nMarch 1, 2023

Via News Direct

RNER Stock Alert: What Is Going on With the HUB Cyber Security Merger? ↗

February 28, 2023

Rainier (RNER) stock soared this morning after the SPAC disclosed that its merger with HUB Cyber Security had been delayed.

Via InvestorPlace

US Stocks Mixed; Dow Drops 100 Points ↗

February 28, 2023

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.36% to 32,769.11 while the NASDAQ rose 0.11%...

Via Benzinga

Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 28, 2023

Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...

Via Benzinga

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket ↗

February 28, 2023

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 28, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

Via InvestorPlace

Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 27, 2023

Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 27, 2023

We're starting off Monday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 26, 2023

We're starting off the day with an overview of the biggest pre-market stock movers that traders need to watch on Thursday!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 05, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!

Via InvestorPlace

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

December 28, 2022

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.